Chitosan-Based Nano Systems for Natural Antioxidants in Breast Cancer Therapy

被引:21
|
作者
Herdiana, Yedi [1 ]
Husni, Patihul [1 ]
Nurhasanah, Siti [2 ]
Shamsuddin, Shaharum [3 ,4 ,5 ]
Wathoni, Nasrul [1 ]
机构
[1] Univ Padjadjaran, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Sumedang 45363, Indonesia
[2] Univ Padjadjaran, Fac Agr Ind Technol, Sumedang 45363, Indonesia
[3] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian 16150, Malaysia
[4] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Nanobiotech Res Initiat, George Town 11800, Malaysia
[5] Univ Sains Malaysia, USM RIKEN Interdisciplinary Collaborat Adv Sci URI, George Town 11800, Malaysia
关键词
breast cancer; bioavailability; chitosan; oral drug delivery; pharmacokinetic; pharmacodynamic properties; OXIDATIVE STRESS; DRUG-DELIVERY; NANOPARTICLES; PHARMACOKINETICS; STRATEGIES; STABILITY; BIODEGRADATION; CHEMOTHERAPY; ENHANCE;
D O I
10.3390/polym15132953
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Breast cancer is a major cause of death globally, accounting for around 13% of all deaths. Chemotherapy, the common treatment for cancer, can have side effects that lead to the production of reactive oxygen species (ROS) and an increase in oxidative stress in the body. Antioxidants are important for maintaining the health of cells and helping the immune system function properly. They play a crucial role in balancing the body's internal environment. Using natural antioxidants is an alternative to mitigate the harmful effects of oxidative stress. However, around 80% of natural antioxidants have limited effectiveness when taken orally because they do not dissolve well in water or other solvents. This poor solubility affects their ability to be absorbed by the body and limits their bioavailability. One strategy that has been considered is to increase their water solubility to increase their oral bioavailability. Chitosan-based nanoparticle (CSNP) systems have been extensively explored due to their reliability and simpler synthesis routes. This review focuses on the various methods of chitosan-based nanoformulation for developing effective oral dosage forms for natural antioxidants based on the pharmacokinetics and pharmacodynamics properties. Chitosan (CS) could be a model, because of its wide use in polymeric NPs research, thus providing a better understanding of the role of vehicles that carry natural antioxidants in maintaining the stability and enhancing the performance of cancer drugs.
引用
收藏
页数:28
相关论文
共 50 条
  • [31] Chitosan-Based Hybrid Nanocomplex for siRNA Delivery and Its Application for Cancer Therapy
    Ki, Min-Hyo
    Kim, Ji-Eon
    Lee, Young-Nam
    Noh, Sang Myoung
    An, Sung-Won
    Cho, Hyun-Jong
    Kim, Dae-Duk
    PHARMACEUTICAL RESEARCH, 2014, 31 (12) : 3323 - 3334
  • [32] Advances in Chitosan-Based Smart Hydrogels for Colorectal Cancer Treatment
    Piotrowska, Urszula
    Orzechowska, Klaudia
    PHARMACEUTICALS, 2024, 17 (10)
  • [33] Chitosan-based nanoconjugate for safe and effective delivery of docetaxel to cancer cells: An explorative study
    Thakur, Gajendra Singh
    Misra, Charu
    Thotakura, Nagarani
    Al Saqr, Ahmed
    Almawash, Saud
    Preet, Simran
    Raza, Kaisar
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 64
  • [34] Chitosan-based systems for the delivery of vaccine antigens
    Arca, H. Cigdem
    Guenbeyaz, Merve
    Senel, Sevda
    EXPERT REVIEW OF VACCINES, 2009, 8 (07) : 937 - 953
  • [35] Chitosan-based Nano-biocomposites and their Applications in Medicine and Pharmaceutics
    Yang, Ziming
    Li, Puwang
    McDonagh, Andrew
    Li, Sidong
    Lv, Mingzhe
    Li, Yongzhen
    Yu, Ziyang
    Feng, Changgen
    CURRENT ORGANIC CHEMISTRY, 2018, 22 (07) : 628 - 640
  • [36] Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer
    Fathi, Marziyeh
    Majidi, Sima
    Zangabad, Parham Sahandi
    Barar, Jaleh
    Erfan-Niya, Hamid
    Omidi, Yadollah
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (06) : 2110 - 2136
  • [37] NEW CHITOSAN-BASED CHEMO PHARMACEUTICAL DELIVERY SYSTEMS FOR TUMOR CANCER TREATMENT: SHORT-REVIEW
    Guarin Gonzalez, Yuly Andrea
    Cardenas Trivino, Galo
    JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2022, 67 (01): : 5425 - 5432
  • [38] Chitosan-Based Therapeutic Systems for Superficial Candidiasis Treatment. Synergetic Activity of Nystatin and Propolis
    Humelnicu, Andra-Cristina
    Samoila, Petrisor
    Cojocaru, Corneliu
    Dumitriu, Raluca
    Bostanaru, Andra-Cristina
    Mares, Mihai
    Harabagiu, Valeria
    Simionescu, Bogdan C.
    POLYMERS, 2022, 14 (04)
  • [39] The Advances in Chitosan-based Drug Delivery Systems for Colorectal Cancer: A Narrative Review
    Ali, Diyar Salahuddin
    Othman, Hazha Omar
    Anwer, Esra Tariq
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023, 24 (12) : 1554 - 1559
  • [40] Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review
    Wang, Guiqiu
    Li, Rilun
    Parseh, Benyamin
    Du, Gang
    CARBOHYDRATE POLYMERS, 2021, 268